We are live on
!
Find out more
SG Americas Securities Portfolio holdings
AUM
$92.9B
1-Year Est. Return
36.98%
This Fund
S&P 500
This Quarter
Est. Return
-6.3%
1 Year Est. Return
+36.98%
3 Year Est. Return
+96.33%
5 Year Est. Return
+110.18%
10 Year Est. Return
+436.29%
AUM
$30.5B
AUM Growth
+$6.11B
(+25%)
Cap. Flow
+$9.67B
Cap. Flow
% of AUM
31.72%
Top 10 Holdings %
Top 10 Hldgs %
46.6%
Holding
3,856
New
751
Increased
1,330
Reduced
1,206
Closed
418
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$507M |
| 3 |
NVIDIA
NVDA
|
+$470M |
| 4 |
Meta Platforms (Facebook)
META
|
+$404M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 2 |
Broadcom
AVGO
|
+$292M |
| 3 |
Oracle
ORCL
|
+$111M |
| 4 |
Microsoft
MSFT
|
+$109M |
| 5 |
Intuit
INTU
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.72% |
| 2 | Communication Services | 17.72% |
| 3 | Healthcare | 7.71% |
| 4 | Financials | 7.66% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Alta Equipment Group
ALTG
$243M
| $52K | ﹤0.01% |
11,068
-2,716
| -20% | -$16.9K |
|
3152
Douglas Elliman
DOUG
$160M
| $52K | ﹤0.01% |
30,448
+16,813
| +123% | +$30.4K |
|
3153
CALL
Medtronic
MDT
$110B
| $52K | ﹤0.01% |
+12,700
| New | +$1.14M |
|
3154
Eledon Pharmaceuticals
ELDN
$269M
| $51K | ﹤0.01% |
+15,089
| New | +$62.1K |
|
|
LAC
3155
Lithium Americas
LAC
$1.08B
| $51K | ﹤0.01% |
18,790
+4,196
| +29% | +$12.6K |
|
3156
MacroGenics
MGNX
$248M
| $51K | ﹤0.01% |
40,440
+6,041
| +18% | +$15.8K |
|
|
IMDX
3157
Insight Molecular Diagnostics
IMDX
$165M
| $51K | ﹤0.01% |
+16,585
| New | +$44.8K |
|
3158
CALL
Southern Company
SO
$107B
| $51K | ﹤0.01% |
30,000
| – | – |
|
3159
Cabaletta Bio
CABA
$452M
| $50K | ﹤0.01% |
36,276
-6,983
| -16% | -$14.9K |
|
3160
Design Therapeutics
DSGN
$826M
| $50K | ﹤0.01% |
12,980
-687
| -5% | -$3.28K |
|
3161
James River Group Holdings
JRVR
$213M
| $50K | ﹤0.01% |
11,862
-3,754
| -24% | -$17K |
|
3162
Oramed Pharmaceuticals
ORMP
$183M
| $50K | ﹤0.01% |
+23,446
| New | +$54.1K |
|
3163
CALL
Constellation Brands
STZ
$22.4B
| $50K | ﹤0.01% |
31,900
-11,500
| -26% | -$2.09M |
|
3164
CALL
CF Industries
CF
$18.1B
| $49K | ﹤0.01% |
57,900
| – | – |
|
3165
Nerdy
NRDY
$107M
| $49K | ﹤0.01% |
34,384
-723
| -2% | -$1.22K |
|
3166
Sight Sciences
SGHT
$307M
| $49K | ﹤0.01% |
20,364
+2,742
| +16% | +$7.72K |
|
3167
Televisa
TV
$1.45B
| $49K | ﹤0.01% |
28,154
| – | – |
|
3168
UNIFI
UFI
$126M
| $49K | ﹤0.01% |
+10,287
| New | +$57.7K |
|
|
EWCZ
3169
DELISTED
European Wax Center
EWCZ
| $48K | ﹤0.01% |
12,244
-3,172
| -21% | -$18.9K |
|
3170
Invivyd
IVVD
$169M
| $48K | ﹤0.01% |
78,845
+29,646
| +60% | +$26.6K |
|
3171
Quantum-Si Incorporated
QSI
$167M
| $48K | ﹤0.01% |
40,079
-27,509
| -41% | -$52.7K |
|
3172
CALL
Centene
CNC
$31.7B
| $47K | ﹤0.01% |
70,400
-339,200
| -83% | -$20.5M |
|
3173
PUT
Pultegroup
PHM
$25.1B
| $45K | ﹤0.01% |
12,500
-8,500
| -40% | -$918K |
|
|
FLNA
3174
Filana Therapeutics
FLNA
$48.1M
| $45K | ﹤0.01% |
29,949
+17,562
| +142% | +$44.3K |
|
3175
Metagenomi Therapeutics
MGX
$45.6M
| $45K | ﹤0.01% |
33,019
+21,009
| +175% | +$50.1K |
|
Similar funds
SG Americas Securities's Q1 2025 Portfolio in Review
As of Q1 2025, SG Americas Securities held 3,856 positions worth $30.5B, up 25% from $24.4B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
SG Americas Securities deployed $9.67B of net new capital in Q1 2025, opening 751 new positions and adding to 1,330 existing holdings. Its largest new stake was Biogen: 719,793 shares worth $98.5M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 40% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $409M trimmed.
- SG Americas Securities's largest Q1 2025 buy was Biogen: 719,793 shares worth $98.5M.
- SG Americas Securities added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $1.46B increase.
- SG Americas Securities's biggest Q1 2025 reduction was Alphabet (Google) Class A, cutting an estimated $409M.
- SG Americas Securities fully exited iShares Ethereum Trust ETF in Q1 2025, selling an estimated $49.8M.
- SG Americas Securities's ten largest holdings make up 47% of its $30.5B portfolio in Q1 2025.
- SG Americas Securities opened 751 new positions and closed 418 in Q1 2025.
- SG Americas Securities's portfolio value rose 25% quarter-over-quarter to $30.5B.
Based on SG Americas Securities's 13F filing for Q1 2025, filed 15 Apr 2025.